220 related articles for article (PubMed ID: 3798078)
1. The pathogenesis of hyperlipoproteinaemia.
Shepherd J; Packard CJ
Scott Med J; 1986 Jul; 31(3):154-61. PubMed ID: 3798078
[TBL] [Abstract][Full Text] [Related]
2. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
Hutt V; Klör HU; Wechsler JG; Ditschuneit H
J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of current perspectives in cholesterol metabolism].
Stalenhoef AF; van 't Laar A
Ned Tijdschr Geneeskd; 1986 May; 130(21):951-5. PubMed ID: 3724871
[No Abstract] [Full Text] [Related]
4. Pathogenesis and management of lipoprotein disorders.
Schaefer EJ; Levy RI
N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163
[No Abstract] [Full Text] [Related]
5. Functional activities of hepatic lipoprotein receptors.
Havel RJ
Annu Rev Physiol; 1986; 48():119-34. PubMed ID: 3010812
[No Abstract] [Full Text] [Related]
6. Genetic hyperlipidemia and atherosclerosis.
Stone NJ
Artery; 1979 May; 5(5):377-97. PubMed ID: 262162
[No Abstract] [Full Text] [Related]
7. [Structure and metabolism of plasma lipoproteins].
Polonovski J; Beucler I
Pathol Biol (Paris); 1983 Apr; 31(4):225-34. PubMed ID: 6346237
[TBL] [Abstract][Full Text] [Related]
8. [Lipoproteins].
Yamamoto A; Yamamura T; Taka-Ich S
Rinsho Byori; 1983 Aug; 31(8):863-73. PubMed ID: 6655919
[No Abstract] [Full Text] [Related]
9. [Congenital abnormalities of plasma lipoprotein metabolism].
Yamamoto A; Yokoyama S
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):760-8. PubMed ID: 3270891
[No Abstract] [Full Text] [Related]
10. Studies on the phenotyping system of hyperlipoproteinemias. Evaluation of a new method by enzymic staining of lipids in serum lipoproteins separated by electrophoresis on agarose.
Ohno F; Suehiro T; Uga S; Kawada M; Takamatsu K; Yasuoka N; Yamano T
Jpn J Med; 1983 Aug; 22(3):200-5. PubMed ID: 6620708
[TBL] [Abstract][Full Text] [Related]
11. Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology.
Mahley RW
Circulation; 1985 Nov; 72(5):943-8. PubMed ID: 4042302
[No Abstract] [Full Text] [Related]
12. Hyperlipoproteinemia: metabolic basis and rationale for therapy.
Grundy SM
Am J Cardiol; 1984 Aug; 54(5):20C-26C. PubMed ID: 6089539
[TBL] [Abstract][Full Text] [Related]
13. [Lipoproteins and arteriosclerosis].
Ras Monleón RM
Med Clin (Barc); 1985 Nov; 85(16):664-6. PubMed ID: 4079562
[No Abstract] [Full Text] [Related]
14. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
15. [Lipoprotein receptor].
Ishikawa T; Kagami A
Nihon Rinsho; 1990 Nov; 48(11):2498-505. PubMed ID: 2176701
[No Abstract] [Full Text] [Related]
16. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein metabolism in liver disease.
Sabesin SM; Bertram PD; Freeman MR
Adv Intern Med; 1980; 25():117-46. PubMed ID: 6987838
[TBL] [Abstract][Full Text] [Related]
18. [Primary hyperlipoproteinemias. Clinical, biological and physiopathological aspects].
Bakir R; Chanu B; Rouffy J
Pathol Biol (Paris); 1983 Apr; 31(4):248-58. PubMed ID: 6346238
[TBL] [Abstract][Full Text] [Related]
19. [Disorders of lipoprotein and cholesterol metabolism in familial hypercholesterolemia].
Wehr H
Pol Arch Med Wewn; 1982; 67(1-2):47-52. PubMed ID: 7050936
[No Abstract] [Full Text] [Related]
20. A simplified approach to lipoprotein kinetics and factors affecting serum cholesterol and triglyceride concentrations.
Hopkins PN; Williams RR
Am J Clin Nutr; 1981 Nov; 34(11):2560-90. PubMed ID: 7030050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
